RASopathies are the most common set of monogenic syndromes identified by exome sequencing for nonimmune hydrops fetalis: A systematic review and meta‐analysis

• Published in: American journal of medical genetics. Part A 2024-05, Vol.194 (5), p.e63494-n/a
• Main Authors: Makhamreh, Mona M., Shivashankar, Kavya, Araji, Sarah, Critchlow, Elizabeth, O'Brien, Barbara M., Wodoslawsky, Sascha, Berger, Seth I., Al‐Kouatly, Huda B.
• Format: Article
• Language: English
• Subjects: Diagnosis; Exome - genetics; Exome Sequencing; Female; Genetic Predisposition to Disease; Genetic screening; Humans; Hydrops fetalis; Hydrops Fetalis - diagnosis; Hydrops Fetalis - genetics; Meta-analysis; Mutation - genetics; nonimmune hydrops fetalis; Pregnancy; Prenatal Diagnosis; RASopathies; Syndrome; Systematic review
• ISSN: 1552-4825; 1552-4833; 1552-4833
• DOI: 10.1002/ajmg.a.63494

RASopathies are a group of malformation syndromes known to lead to nonimmune hydrops fetalis (NIHF) in severe presentations. Pathogenic variants can be de novo or parentally inherited. Despite being a known frequent presentation, the fraction of monogenic NIHF cases due to RASopathies is limited in the literature. Also, the specific parental contribution of RASopathies to NIHF is not well described. Our objective was to review pooled exome sequencing (ES) diagnostic yield of RASopathies for NIHF and to determine the parental contribution of RASopathy to NIHF. We performed a systematic review of prenatal ES studies from January 1, 2000 to August 1, 2022. Thirty‐six studies met inclusion criteria. Cases with RASopathy gene variants were reviewed. NIHF cases were further classified as isolated or non‐isolated. Thirty‐six ES studies including 46 pregnancies with NIHF and a diagnosed RASopathy were reviewed. Forty‐four diagnostic variants and 2 variants of uncertain significance in 12 RASopathy genes were identified. Expanding on what was previously published, a total of 506 NIHF cases were extracted with 191 cases yielding a positive diagnosis by ES. The overall rate of RASopathy diagnosis in clinically diagnosed NIHF cases was 9% (44/506). The rate of RASopathy diagnosis among NIHF cases with positive genetic diagnosis by ES was 23% (44/191). Of the 46 cases identified, 13 (28%) variants were parentally inherited; specifically, 5/13 (38%) maternal, 3/13 (23%) paternal, 2/13 (15%) biparental, and 3/13 (23%) unspecified. Majority of NIHF cases 29/46 (63%) were isolated. Among NIHF cases with positive ES diagnoses, RASopathy diagnostic yield by ES was 23%. NIHF secondary to RASopathies was parentally inherited in 28% of cases. Most cases of NIHF due to RASopathy were isolated, with no prenatal detection of associated anomalies.